NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve the management of Bacillus Calmette-Guerin (BCG) unresponsiveness in nonmuscle invasive bladder cancer (NMIBC). After hearing and assimilating this program, the clinicians will be able to:
1. Develop an appropriate treatment regimen with maintenance doses of BCG in patients with NIMBC.
2. Select appropriate treatments for BCG unresponsiveness in patients with NIMBC.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Urology
- Start Date: 2022-06-30 05:00:00
- End Date: 2022-06-30 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest